The Hormone Manufacturing facility was constructed on an existing site of DRL.
Area of production block is approx. 1500 Sq.M with a batch size of 50kg/month. The project cost was Rs. 250 million and was completed in 10 months.
The facility has two dedicated self-contained modules for manufacturing two products simultaneously. The facility was design for PBOEL (Performance Based Operator Exposure Limit) of 500 ng/cu.m. Based on this risk assessment Containment levels were decided.
Dedicated detoxification reactor is provided to detoxify the effluent before discharging it to a common Effluent Treatment Plant.
Spectrum provided critical inputs during planning stage to minimize handling of potent product in powder form. The risk elimination at source technique was used minimizing operator interface.
This facility has been approved by USFDA. |